NCT04262232

Brief Summary

The Cancer Health Empowerment for Living without Pain (Ca-HELP) is an evidence-based communication tool that empowers and engages patients to communicate effectively with their physicians about pain. The Ca-HELP intervention is rooted in social-cognitive theory which posits that behavior change and maintenance depends largely on individuals' ability and self-efficacy to execute a specific behavior. Ca-HELP coaches patients to ask questions, make requests, and signal distress to their physicians in order to achieve improved pain control. Previous research indicates significant improvement among cancer patients in their self-efficacy to communicate about their pain to their oncologists and reductions in pain misconceptions and pain-related impairment. Although a promising tool among geriatric cancer patients, Ca-HELP is not currently designed for optimal dissemination in rural settings.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable pain

Timeline
Completed

Started May 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 6, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

February 10, 2020

Completed
1.2 years until next milestone

Study Start

First participant enrolled

May 1, 2021

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 5, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 5, 2022

Completed
10 months until next milestone

Results Posted

Study results publicly available

March 13, 2023

Completed
Last Updated

March 22, 2023

Status Verified

March 1, 2023

Enrollment Period

1 year

First QC Date

February 6, 2020

Results QC Date

February 13, 2023

Last Update Submit

March 20, 2023

Conditions

Outcome Measures

Primary Outcomes (9)

  • Feasibility (Aim 2), as Measured by Number of Subjects Accrued to the Study

    Number of subjects accrued

    Two weeks post-intervention

  • Feasibility (Aim 2), as Measured by Number of Subjects to Complete the Intervention

    Number of subjects to complete intervention

    Two weeks post-intervention

  • Acceptability (Aim 2), as Measured by Qualitative Feedback

    Semi-structured interview assessing perceived satisfaction, helpfulness, usability, and readability. This interview will be coded qualitatively for themes that assess these components for assessment of overall acceptability. Qualitative data was analyzed as number of subjects endorsing specific themes. Themes around usability and readability did not emerge from the semi-structured interviews, thus no data on usability or readability were available to analyze.

    Two weeks post-intervention

  • Acceptability (Aim 2), as Measured by Helpfulness

    Likert scale item assessing perceived helpfulness. Likert scale from 1 (not at all helpful) to 5 (very helpful), with 5 indicating higher levels of acceptability.

    Two weeks post-intervention

  • Acceptability (Aim 2), as Measured by Satisfaction

    Likert scale item assessing perceived satisfaction. Likert scale from 1 (not at all satisfied) to 5 (very satisfied), with 5 indicating higher levels of acceptability.

    Two weeks post-intervention

  • Acceptability (Aim 2), as Measured by Usability

    Likert scale item assessing perceived usability by assessing how difficult the intervention content was to understand. Likert scale from 1 (not at all) to 5 (very much). The item was reverse scored so that 5 indicates higher levels of acceptability.

    Two weeks post-intervention

  • Acceptability (Aim 2), as Measured by Readability

    Yes/no items assessing perceived readability (wording was too complicated, ideas were too complicated, there was too much information, there was not enough information). Individual items will be summed to create a total readability score. Scores can range from 0 (no issues/ good readability) to 4 (poor readability). \*Note these questions were only answered among participants who indicated that the intervention content was difficult to understand (eg, poor usability) by scoring \>1 on the 1 to 5 Likert-scale of usability.

    Two weeks post-intervention

  • Change in Pain Self-management (Aim 3)

    Two items from the pain management subscale of the Chronic Pain Self-Efficacy scale. Items rated on a 5-point Likert scale (1 = not at all certain and 5 = extremely certain). Scores range from 2 (low self-management) to 10 (high self-management).

    Baseline, two weeks post-intervention

  • Change in Pain Misconceptions (Aim 3)

    Assessed using the 11 items based on the short version of the Barriers Questionnaire. Items are rated on a five-point Likert scale (1=disagree very much, 5=agree very much). Scores range from 1 (low misconception) to 5 (high misconception) as an average across all 11 items.

    Baseline, two weeks post-intervention

Secondary Outcomes (4)

  • Treatment Fidelity as Measured by Number of Subjects for Which the Intervention Was Delivered With Fidelity

    Two weeks post-intervention

  • Change in Self-efficacy for Communicating With Physicians About Pain Severity

    Baseline, two weeks post-intervention

  • Change in Pain-related Impairment

    Baseline, two weeks post-intervention

  • Change in Pain Severity

    Baseline, two weeks post-intervention

Study Arms (1)

Ca-HELP

EXPERIMENTAL

This intervention arm will consist of six components: (1) Assessment of current knowledge, attitudes, and preferences; (2) clarification and correction of misconceptions about cancer pain control; (3) teaching of relevant concepts (education about cancer pain control); (4) planning (identifying goals of care, creating achievable goals of care, and creating strategies to communicate goals of care to providers and family members); (5) rehearsal of communication strategies using role play exercises; and (6) portrayal of learned skills (patient applies skills in visit with healthcare provider).

Behavioral: Adapted Ca-HELP for Geriatric Cancer Patients

Interventions

Intervention group: This intervention will be informed by social-cognitive theory10-13 and modeled after the tailored education and coaching intervention (TEC) used for Ca-HELP previously and consists of six components: (1) Assessment of current knowledge, attitudes, and preferences; (2) clarification and correction of misconceptions about cancer pain control; (3) teaching of relevant concepts (education about cancer pain control); (4) planning (identifying goals of care, creating achievable goals of care, and creating strategies to communicate goals of care to providers and family members); (5) rehearsal of communication strategies using role play exercises; and (6) portrayal of learned skills (patient applies skills in visit with healthcare provider).

Ca-HELP

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • years of age or older
  • Diagnosed with cancer
  • English speaking
  • Reside in non-institutional, rural settings
  • Receive care at community-based clinic in rural area
  • Ability to provide informed consent
  • Have identified an informal caregiver.

You may not qualify if:

  • Severe cognitively impairment (Short Portable Mental Status Questionnaire scores of \<6);
  • Receiving hospice at time of enrollment.
  • Caregiver eligibility criteria include the following
  • The person (family member or friend) whom the patient indicates provides most of their informal care
  • Able to provide informed consent.
  • Provider eligibility criteria:
  • Currently works with geriatric cancer patients OR in a healthcare system serving this patient population. Providers will include social workers, nurses, oncologists, and healthcare administrators.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Maury Regional Medical Center

Columbia, Tennessee, 38401, United States

Location

MeSH Terms

Conditions

Pain

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Megan Shen
Organization
Fred Hutchinson Cancer Center

Study Officials

  • Cary Reid, MD, PhD

    Weill Medical College of Cornell University

    PRINCIPAL INVESTIGATOR
  • Megan Shen, PhD

    Fred Hutchinson Cancer Center

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Masking Details
No masking due to this being a single arm study.
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Model Details: This is a single arm study in which all participants will be exposed to the intervention (Ca-HELP).
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 6, 2020

First Posted

February 10, 2020

Study Start

May 1, 2021

Primary Completion

May 5, 2022

Study Completion

May 5, 2022

Last Updated

March 22, 2023

Results First Posted

March 13, 2023

Record last verified: 2023-03

Data Sharing

IPD Sharing
Will not share

Locations